Indefinite Delivery Contract 75F40123D00013
Award Date
5/16/23
Last Date to Order
5/16/25
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances. Two task orders have been issued under this IDC. The...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides,...
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Research Triangle Institute (RTI International), a non-profit research organization, for ECONOMIC STUDIES OF FDA REGULATIONS. The single-award IDC has a ceiling value of $5,000,000.00 and a period of performance through September 19, 2029. Under this contract, RTI International will provide a range of technical and advisory services to support the FDA's regulatory and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Research Triangle Institute (RTI International), a non-profit research organization, for the "Economic Studies of FDA Regulations" program. The $9,901,000 multiple-award IDC has a period of performance through September 14, 2024. Under this IDC, RTI has been issued several delivery orders, including: A $0 task order to develop an economic...
This Indefinite Delivery Contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Circana, LLC (doing business as Infoscan), a for-profit data and analytics firm. The single-award $20,001,000.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract runs from April 2, 2024 through April 1, 2029 and serves as a comprehensive vehicle for the FDA and potentially other federal partners to access Circana's consumer insights, data, and analytics services through...
This is a single-award Indefinite Delivery Contract (IDC) awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Metabolon, Inc., a small disadvantaged business. The contract has a ceiling value of $296,000.00 and a period of performance through August 1, 2030. The purpose of this IDC is to provide the FDA with indefinite delivery/indefinite quantity (IDIQ) services for metabolomic analysis of biological samples. Metabolon, as the prime contractor, will utilize its...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to the National Academy of Sciences with a potential value of $30,000,000.00. The contract establishes a forum for the agency to convene committees for assessment, evaluations, and studies related to public health issues. Five task orders have been awarded against the contract to date, with periods of performance ranging from September 2022 through September 2025. Task orders...
The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Source Healthcare Analytics LLC with a potential value of $45 million. Under the contract, Source Healthcare will provide the FDA access to outpatient prescription and patient level drug utilization data over a five-year period ending in May 2025. Task Order 1 was issued with a firm fixed price value of $20.2 million. Source Healthcare will support the FDA's efforts...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Iqvia Government Solutions Inc., a prominent healthcare data and analytics provider. The contract, valued at up to $3,169,963.15, provides the FDA with access to over-the-counter (OTC) drug utilization data to strengthen the agency's drug monitoring and safety surveillance programs. Through a series of firm fixed price delivery...